ASTELLAS PHARMA INC. Tokyo, March 4, 2016 - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka) today announced the personnel changes as below.
-
Appointment of Corporate Executive effective on April 1, 2016
Name
New Title
Current Title
Yukio Matsui
President,
EMEA Operations
Senior Vice President,
Head of Marketing Strategy
*EMEA: Europe, Middle East and Africa
- Personnel Change effective on April 1, 2016
Name | New Title | Current Title |
Martin Golden | Senior Vice President, Head of Marketing Strategy | Vice President, Government Affairs Astellas Pharma US, Inc. |
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at www.astellas.com/en.
###
Contacts for inquiries or additional information Astellas Pharma Inc.
Corporate Communications
TEL: 03-3244-3201 FAX: 03-5201-7473
http://www.astellas.com/en
2
Astellas Pharma Inc. issued this content on 04 March 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 04 March 2016 06:15:18 UTC
Original Document: http://www.astellas.com/en/corporate/news/pdf/160304_1_Eg.pdf
